Aaron Michels
Has grant
Associate Professor
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Aaron Michels is an Associate Professor at the University of Colorado Denver School of Medicine in the United States. His research primarily focuses on Type 1 Diabetes, including the pathogenesis, genetic factors, and immune responses involved in the disease. Recent work includes studies on autoantibodies, T cell receptors, and the clinical features of Type 1 Diabetes in diverse populations.
Recent Grants
Grant: Close
Effect of methyldopa on MHC antigen presentation in type 1 diabetes
Open Date: 2014-05-01
Close Date: 2016-04-30
Grant: Close
Effect of methyldopa on MHC antigen presentation in type 1 diabetes
Open Date: 2014-05-01
Close Date: 2016-04-30
Grant: Close
Small Molecules Targeting Allele Specific MHC Class II Presentation
Open Date: 2012-07-01
Close Date: 2017-04-30
Grant: Close
Small Molecules Targeting Allele Specific MHC Class II Presentation
Open Date: 2012-07-01
Close Date: 2017-04-30
Grant: Close
Small molecules targeting the tri-molecular complex
Open Date: 2010-06-01
Close Date: 2013-05-31
Articles (9)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2020
Collaborators (8)
Sarah Richardson
Associate Professor in Cellular Biomedicine
University of Exeter
Maria Skjøtt Hansen
Professional Research Assistant
University of Colorado Anschutz Medical Campus
Liping Yu
University of Colorado School of Medicine
Dirk Homann
Icahn School of Medicine at Mount Sinai
Iria Gomez-Touriño
Associate Professor
Universidade de Santiago de Compostela
Laura Pyle
University of Washington
Taylor Triolo
Assistant Professor
Barbara Davis Center for Childhood Diabetes
Eline Luning Prak
Professor
University of Pennsylvania Perelman School of Medicine
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.